MESIAL TEMPORAL LOBE EPILEPSY
Clinical trials for MESIAL TEMPORAL LOBE EPILEPSY explained in plain language.
Never miss a new study
Get alerted when new MESIAL TEMPORAL LOBE EPILEPSY trials appear
Sign up with your email to follow new studies for MESIAL TEMPORAL LOBE EPILEPSY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain cell transplant aims to calm seizures in drug-resistant epilepsy
Disease control Recruiting nowThis study tests a one-time injection of special brain cells (NRTX-1001) into the seizure area for people with drug-resistant mesial temporal lobe epilepsy. The cells release GABA, a natural chemical that calms overactive nerves. Researchers will compare seizure reduction and saf…
Matched conditions: MESIAL TEMPORAL LOBE EPILEPSY
Phase: PHASE3 • Sponsor: Neurona Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Gene therapy injection aims to quiet seizures in Drug-Resistant epilepsy
Disease control Recruiting nowThis early-stage study tests a new gene therapy called AMT-260 in 12 adults with a specific type of epilepsy (mesial temporal lobe epilepsy) that does not respond to standard medications. The treatment is delivered directly into the brain using MRI guidance. The main goals are to…
Matched conditions: MESIAL TEMPORAL LOBE EPILEPSY
Phase: PHASE1, PHASE2 • Sponsor: UniQure Biopharma B.V. • Aim: Disease control
Last updated May 11, 2026 20:37 UTC
-
Could targeted brain zaps tame tough seizures?
Disease control Recruiting nowThis study tests a new way to use deep brain stimulation (DBS) for people with epilepsy that starts in the memory part of the brain. Eight participants will get a device that sends low-frequency electrical pulses to specific brain networks. The goal is to reduce seizures and impr…
Matched conditions: MESIAL TEMPORAL LOBE EPILEPSY
Phase: NA • Sponsor: Nitin Tandon • Aim: Disease control
Last updated May 04, 2026 16:17 UTC